Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2023 May 17;14:2817. doi: 10.1038/s41467-023-38561-y

Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma

Yige Wu 1,2,#, Nadezhda V Terekhanova 1,2,#, Wagma Caravan 1,2,#, Nataly Naser Al Deen 1,2,#, Preet Lal 1,#, Siqi Chen 1,2, Chia-Kuei Mo 1,2, Song Cao 1,2, Yize Li 1,2, Alla Karpova 1,2, Ruiyang Liu 1,2, Yanyan Zhao 1, Andrew Shinkle 1,2, Ilya Strunilin 1,2, Cody Weimholt 3, Kazuhito Sato 1, Lijun Yao 1,2, Mamatha Serasanambati 1, Xiaolu Yang 1, Matthew Wyczalkowski 1,2, Houxiang Zhu 1,2, Daniel Cui Zhou 1,2, Reyka G Jayasinghe 1,2, Daniel Mendez 1, Michael C Wendl 1,2,4,5, David Clark 6, Chelsea Newton 7, Yijun Ruan 8, Melissa A Reimers 1,9, Russell K Pachynski 1,9, Chris Kinsinger 10, Scott Jewell 7, Daniel W Chan 6, Hui Zhang 6, Aadel A Chaudhuri 4,11,12, Milan G Chheda 1,9, Benjamin D Humphreys 1, Mehdi Mesri 10, Henry Rodriguez 10, James J Hsieh 1, Li Ding 1,2,4,12,✉, Feng Chen 1,12,✉
PMCID: PMC10192256  PMID: 37198186

Correction to: Nature Communications 10.1038/s41467-023-37211-7, published online 27 March 2023

In the Acknowledgements section of this article, the grant number relating to US National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium given for Li Ding was incorrectly given as U24CA210976 and should have been U24CA210972. The original article has been corrected.

Contributor Information

Li Ding, Email: lding@wustl.edu.

Feng Chen, Email: fchen@wustl.edu.

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES